186 related articles for article (PubMed ID: 30659195)
21. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma.
Chen YR; Ouyang SS; Chen YL; Li P; Xu HW; Zhu SL
Aging (Albany NY); 2020 Sep; 12(17):17541-17567. PubMed ID: 32927435
[TBL] [Abstract][Full Text] [Related]
22. A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells.
Guo L; Li J; Zeng H; Guzman AG; Li T; Lee M; Zhou Y; Goodell MA; Stephan C; Davies PJA; Dawson MA; Sun D; Huang Y
Nat Commun; 2020 Feb; 11(1):740. PubMed ID: 32029739
[TBL] [Abstract][Full Text] [Related]
23. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.
Li K; Liu Y; Cao H; Zhang Y; Gu Z; Liu X; Yu A; Kaphle P; Dickerson KE; Ni M; Xu J
Nat Commun; 2020 Jan; 11(1):485. PubMed ID: 31980609
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
[TBL] [Abstract][Full Text] [Related]
25. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2.
Zhu X; Zhang T; Zhang Y; Chen H; Shen J; Jin X; Wei J; Zhang E; Xiao M; Fan Y; Mao R; Zhou G
Cell Signal; 2020 Feb; 66():109470. PubMed ID: 31730895
[TBL] [Abstract][Full Text] [Related]
26. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
27. RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Mill CP; Fiskus W; DiNardo CD; Qian Y; Raina K; Rajapakshe K; Perera D; Coarfa C; Kadia TM; Khoury JD; Saenz DT; Saenz DN; Illendula A; Takahashi K; Kornblau SM; Green MR; Futreal AP; Bushweller JH; Crews CM; Bhalla KN
Blood; 2019 Jul; 134(1):59-73. PubMed ID: 31023702
[TBL] [Abstract][Full Text] [Related]
28.
Gu X; Wang L; Boldrup L; Coates PJ; Fahraeus R; Sgaramella N; Wilms T; Nylander K
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862109
[TBL] [Abstract][Full Text] [Related]
29. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg.
Fernández-Barrena MG; Arechederra M; Colyn L; Berasain C; Avila MA
JHEP Rep; 2020 Dec; 2(6):100167. PubMed ID: 33134907
[TBL] [Abstract][Full Text] [Related]
30. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ.
Della Chiara G; Gervasoni F; Fakiola M; Godano C; D'Oria C; Azzolin L; Bonnal RJP; Moreni G; Drufuca L; Rossetti G; Ranzani V; Bason R; De Simone M; Panariello F; Ferrari I; Fabbris T; Zanconato F; Forcato M; Romano O; Caroli J; Gruarin P; Sarnicola ML; Cordenonsi M; Bardelli A; Zucchini N; Ceretti AP; Mariani NM; Cassingena A; Sartore-Bianchi A; Testa G; Gianotti L; Opocher E; Pisati F; Tripodo C; Macino G; Siena S; Bicciato S; Piccolo S; Pagani M
Nat Commun; 2021 Apr; 12(1):2340. PubMed ID: 33879786
[TBL] [Abstract][Full Text] [Related]
31. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling.
Huang H; Hu J; Maryam A; Huang Q; Zhang Y; Ramakrishnan S; Li J; Ma H; Ma VWS; Cheuk W; So GYK; Wang W; Cho WCS; Zhang L; Chan KM; Wang X; Chin YR
Nat Commun; 2021 Apr; 12(1):2242. PubMed ID: 33854062
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor DNA and Hepatocellular Carcinoma.
Yang JD; Liu MC; Kisiel JB
Semin Liver Dis; 2019 Nov; 39(4):452-462. PubMed ID: 31226727
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics of hepatocellular carcinoma.
Toh TB; Lim JJ; Chow EK
Clin Transl Med; 2019 May; 8(1):13. PubMed ID: 31056726
[TBL] [Abstract][Full Text] [Related]
34. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
35. TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation.
Li X; He W; Chen X; Zhang Y; Zhang J; Liu F; Li J; Zhao D; Xia P; Ma W; Wu T; Wang H; Yuan Y
Oncogene; 2024 May; ():. PubMed ID: 38755308
[TBL] [Abstract][Full Text] [Related]
36. Chinmedomics: a potent tool for the evaluation of traditional Chinese medicine efficacy and identification of its active components.
Wang M; Yin F; Kong L; Yang L; Sun H; Sun Y; Yan G; Han Y; Wang X
Chin Med; 2024 Mar; 19(1):47. PubMed ID: 38481256
[TBL] [Abstract][Full Text] [Related]
37. Enhancer Recognition: A Transformer Encoder-Based Method with WGAN-GP for Data Augmentation.
Feng T; Hu T; Liu W; Zhang Y
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139375
[TBL] [Abstract][Full Text] [Related]
38. Global research hotspots and frontier trends of epigenetic modifications in autoimmune diseases: A bibliometric analysis from 2012 to 2022.
Gao X; Huang X; Wang Y; Sun S; Chen T; Gao Y; Zhang X
Medicine (Baltimore); 2023 Sep; 102(39):e35221. PubMed ID: 37773838
[TBL] [Abstract][Full Text] [Related]
39. Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.
Zhang N; Tian X; Yan T; Wang H; Zhang D; Lin C; Liu Q; Jiang S
Front Immunol; 2023; 14():1148722. PubMed ID: 37020540
[TBL] [Abstract][Full Text] [Related]
40. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
